Editorial
doi: 10.1056/NEJMe1112770.
Epub 2011 Nov 13.
A new era in secondary prevention after acute coronary syndrome
- PMID: 22077849
- DOI: 10.1056/NEJMe1112770
Item in Clipboard
Editorial
A new era in secondary prevention after acute coronary syndrome
N Engl J Med.
.
No abstract available
Comment on
-
Rivaroxaban in patients with a recent acute coronary syndrome.N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13. N Engl J Med. 2012. PMID: 22077192 Clinical Trial.
Similar articles
-
Rivaroxaban in acute coronary syndromes--is it prime time?Expert Rev Cardiovasc Ther. 2014 Jun;12(6):649-58. doi: 10.1586/14779072.2014.910118. Epub 2014 Apr 19. Expert Rev Cardiovasc Ther. 2014. PMID: 24746010 Review.
-
Rivaroxaban in patients with a recent acute coronary syndrome event: integration of trial findings into clinical practice.Vasc Health Risk Manag. 2014 May 12;10:291-302. doi: 10.2147/VHRM.S59420. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24868164 Free PMC article. Review.
-
Rivaroxaban in acute coronary syndromes and atrial fibrillation: rivaroxaban shown to reduce cardiovascular deaths in STEMI patients.Cardiovasc J Afr. 2012 Oct;23(9):525-6. Cardiovasc J Afr. 2012. PMID: 23108522 No abstract available.
-
Response to "Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban".J Clin Pharmacol. 2011 Jul;51(7):1122-3. doi: 10.1177/0091270010377503. J Clin Pharmacol. 2011. PMID: 21666147 No abstract available.
-
["Xa-tra-xa": opportunities and open questions about new anticoagulants].Praxis (Bern 1994). 2011 Aug 10;100(16):947. doi: 10.1024/1661-8157/a000626. Praxis (Bern 1994). 2011. PMID: 21910293 German. No abstract available.
Cited by
-
Low dose rivaroxaban for the management of atherosclerotic cardiovascular disease.J Thromb Thrombolysis. 2023 Jul;56(1):91-102. doi: 10.1007/s11239-023-02821-x. Epub 2023 May 6. J Thromb Thrombolysis. 2023. PMID: 37148437 Review.
-
Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction.Mol Ther. 2022 Feb 2;30(2):881-897. doi: 10.1016/j.ymthe.2021.10.005. Epub 2021 Oct 8. Mol Ther. 2022. PMID: 34628054 Free PMC article.
-
ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure.Antioxidants (Basel). 2021 Mar 5;10(3):396. doi: 10.3390/antiox10030396. Antioxidants (Basel). 2021. PMID: 33807982 Free PMC article.
-
Hematopoiesis and Cardiovascular Disease.Circ Res. 2020 Apr 10;126(8):1061-1085. doi: 10.1161/CIRCRESAHA.120.315895. Epub 2020 Apr 9. Circ Res. 2020. PMID: 32271679 Free PMC article. Review.
-
Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models.Mediators Inflamm. 2017;2017:9746169. doi: 10.1155/2017/9746169. Epub 2017 Mar 30. Mediators Inflamm. 2017. PMID: 28465628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
